These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 19617578)

  • 1. How I treat amyloidosis.
    Comenzo RL
    Blood; 2009 Oct; 114(15):3147-57. PubMed ID: 19617578
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Coexistent asymptomatic myeloma and hereditary cardiac amyloidosis: an unusual case of heart failure.
    Lee L; Aziz M; Wechalekar A; Rabin N
    Br J Hosp Med (Lond); 2011 Nov; 72(11):650-1. PubMed ID: 22083004
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiac amyloidosis: a practical approach to diagnosis and management.
    Kapoor P; Thenappan T; Singh E; Kumar S; Greipp PR
    Am J Med; 2011 Nov; 124(11):1006-15. PubMed ID: 22017778
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heart failure and cardiac involvement as isolated manifestation of familial form of transthyretin amyloidosis resulting from Val30Met mutation with no clinical signs of polyneuropathy.
    Christoph DC; Boese D; Johnson KT; Schlosser TW; Hunold P; Baba HA; Erbel R; Philipp S
    Circ Heart Fail; 2009 Sep; 2(5):512-5. PubMed ID: 19808383
    [No Abstract]   [Full Text] [Related]  

  • 5. Hereditary transthyretin amyloidosis: molecular basis and therapeutical strategies.
    Saraiva MJ
    Expert Rev Mol Med; 2002 May; 4(12):1-11. PubMed ID: 14987380
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Amyloid fibrils containing fragmented ATTR may be the standard fibril composition in ATTR amyloidosis.
    Ihse E; Rapezzi C; Merlini G; Benson MD; Ando Y; Suhr OB; Ikeda S; Lavatelli F; Obici L; Quarta CC; Leone O; Jono H; Ueda M; Lorenzini M; Liepnieks J; Ohshima T; Tasaki M; Yamashita T; Westermark P
    Amyloid; 2013 Sep; 20(3):142-50. PubMed ID: 23713495
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The diagnostic challenges of cardiac amyloidosis: A practical approach to the two main types.
    Varga C; Dorbala S; Lousada I; Polydefkis MJ; Wechalekar A; Maurer MS; Comenzo RL
    Blood Rev; 2021 Jan; 45():100720. PubMed ID: 32616304
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Seeking confidence in the diagnosis of systemic AL (Ig light-chain) amyloidosis: patients can have both monoclonal gammopathies and hereditary amyloid proteins.
    Comenzo RL; Zhou P; Fleisher M; Clark B; Teruya-Feldstein J
    Blood; 2006 May; 107(9):3489-91. PubMed ID: 16439680
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Fibril-forming proteins: the amyloidosis. New hopes for a disease that cardiologists must know].
    Arbustini E; Gavazzi A; Merlini G
    Ital Heart J Suppl; 2002 Jun; 3(6):590-7. PubMed ID: 12116807
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of germline mutations in the TTR gene in a consecutive series of surgical pathology specimens with ATTR amyloid.
    Eriksson M; Büttner J; Todorov T; Yumlu S; Schönland S; Hegenbart U; Kristen AV; Dengler T; Lohse P; Helmke B; Schmidt H; Röcken C
    Am J Surg Pathol; 2009 Jan; 33(1):58-65. PubMed ID: 18830126
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transthyretin-related amyloidoses and the heart: a clinical overview.
    Rapezzi C; Quarta CC; Riva L; Longhi S; Gallelli I; Lorenzini M; Ciliberti P; Biagini E; Salvi F; Branzi A
    Nat Rev Cardiol; 2010 Jul; 7(7):398-408. PubMed ID: 20479782
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Direct tissue evaluation via immunofluorescence: in the diagnosis of hereditary transthyretin cardiac amyloidosis.
    Fradley MG; Thakuria JV; Collins AB; Moore SA; Stone JR
    Tex Heart Inst J; 2012; 39(1):71-5. PubMed ID: 22412233
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heart failure caused by a novel amyloidogenic mutation of the transthyretin gene: ATTR Ala45Ser.
    Janunger T; Anan I; Holmgren G; Lövheim O; Ohlsson PI; Suhr OB; Tashima K
    Amyloid; 2000 Jun; 7(2):137-40. PubMed ID: 10842718
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diagnostic performance of 123I-labeled serum amyloid P component scintigraphy in patients with amyloidosis.
    Hazenberg BP; van Rijswijk MH; Piers DA; Lub-de Hooge MN; Vellenga E; Haagsma EB; Hawkins PN; Jager PL
    Am J Med; 2006 Apr; 119(4):355.e15-24. PubMed ID: 16564782
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of S-sulfonation and S-thiolation of a novel transthyretin Phe33Cys variant from a patient diagnosed with familial transthyretin amyloidosis.
    Lim A; Prokaeva T; McComb ME; Connors LH; Skinner M; Costello CE
    Protein Sci; 2003 Aug; 12(8):1775-85. PubMed ID: 12876326
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transthyretin (ATTR) amyloidosis: clinical spectrum, molecular pathogenesis and disease-modifying treatments.
    Sekijima Y
    J Neurol Neurosurg Psychiatry; 2015 Sep; 86(9):1036-43. PubMed ID: 25604431
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential recruitment efficacy of patient-derived amyloidogenic and myeloma light chain proteins by synthetic fibrils-A metric for predicting amyloid propensity.
    Martin EB; Williams A; Wooliver C; Heidel RE; Adams S; Dunlap J; Ramirez-Alvarado M; Blancas-Mejia LM; Lands RH; Kennel SJ; Wall JS
    PLoS One; 2017; 12(3):e0174152. PubMed ID: 28350808
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amyloid in endomyocardial biopsies.
    Kieninger B; Eriksson M; Kandolf R; Schnabel PA; Schönland S; Kristen AV; Hegenbart U; Lohse P; Röcken C
    Virchows Arch; 2010 May; 456(5):523-32. PubMed ID: 20376481
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel type of familial transthyretin amyloidosis, ATTR Asn124Ser, with co-localization of kappa light chains.
    Bergström J; Patrosso MC; Colussi G; Salvadore M; Penco S; Lando G; Marocchi A; Ueda A; Nakamura M; Ando Y
    Amyloid; 2007 Jun; 14(2):141-5. PubMed ID: 17577687
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tafamidis: a selective transthyretin stabilizer to treat wild-type ATTR amyloidosis and hereditary ATTR amyloidosis with cardiomyopathy.
    Paton DM
    Drugs Today (Barc); 2019 Dec; 55(12):727-734. PubMed ID: 31942875
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.